No abstract available
MeSH terms
-
Antipsychotic Agents / pharmacokinetics*
-
Antipsychotic Agents / therapeutic use
-
Clozapine / pharmacokinetics*
-
Clozapine / therapeutic use
-
Corpus Striatum / drug effects*
-
Corpus Striatum / physiopathology
-
Dopamine / physiology*
-
Dopamine Antagonists / pharmacokinetics*
-
Dopamine Antagonists / therapeutic use
-
Dopamine D2 Receptor Antagonists
-
Humans
-
Limbic System / drug effects
-
Limbic System / physiopathology
-
Receptor, Serotonin, 5-HT2A
-
Receptors, Adrenergic, alpha-2 / drug effects
-
Receptors, Adrenergic, alpha-2 / physiology
-
Receptors, Dopamine D2 / drug effects
-
Receptors, Dopamine D2 / physiology*
-
Receptors, Dopamine D4
-
Receptors, Serotonin / drug effects
-
Receptors, Serotonin / physiology
-
Schizophrenia / drug therapy*
-
Schizophrenia / metabolism
-
Serotonin / physiology
-
Substrate Specificity
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
DRD4 protein, human
-
Dopamine Antagonists
-
Dopamine D2 Receptor Antagonists
-
Receptor, Serotonin, 5-HT2A
-
Receptors, Adrenergic, alpha-2
-
Receptors, Dopamine D2
-
Receptors, Serotonin
-
Receptors, Dopamine D4
-
Serotonin
-
Clozapine
-
Dopamine